BRIEF published on 06/18/2026 at 13:57, 2 months 9 days ago ABL Diagnostics prévoit une croissance notable et un fort potentiel de développement. Partenariats Stratégiques Recommandation D'achat Augmentation Des Revenus Croissance 2026 Diagnostics ABL
BRIEF published on 06/18/2026 at 13:57, 2 months 9 days ago ABL Diagnostics : Croissance et Perspectives pour 2026 Croissance Partenariats INVEST SECURITIES Diagnostic Moléculaire Génotypage
BRIEF published on 06/18/2026 at 13:57, 2 months 9 days ago ABL Diagnostics Projects Notable Growth and Upward Potential Strategic Partnerships Revenue Increase Buy Recommendation ABL Diagnostics Growth 2026
BRIEF published on 06/18/2026 at 13:57, 2 months 9 days ago ABL Diagnostics: Growth and Outlook for 2026 INVEST SECURITIES Growth Partnerships Molecular Diagnosis Genotyping
PRESS RELEASE published on 06/18/2026 at 13:52, 2 months 9 days ago Informations privilégiées / Autres communiqués ABL Diagnostics confirme sa trajectoire de croissance avec un fort levier de revalorisation identifié. Recommandation d'achat avec objectif de cours à 8,7€ Croissance Recommandation D'achat Objectif De Cours Diagnostic Moléculaire ABL Diagnostics
PRESS RELEASE published on 06/18/2026 at 13:52, 2 months 9 days ago Inside Information / Other news releases ABL Diagnostics confirms growth trajectory with strong upside potential. Invest Securities raises target price to €8.7 and maintains 'Buy' recommendation INVEST SECURITIES Target Price Growth Trajectory Upside Potential ABL Diagnostics
BRIEF published on 06/12/2026 at 08:05, 2 months 15 days ago ABL Diagnostics and CDL Pharma sign a €2.7 million contract until 2031 Clinical Trials Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma
BRIEF published on 06/12/2026 at 08:05, 2 months 15 days ago ABL Diagnostics et CDL Pharma signent un contrat de 2,7 M€ jusqu'en 2031 Essais Cliniques Maladies Neurodégénératives ABL Diagnostics Contrat Pluriannuel CDL Pharma
BRIEF published on 06/12/2026 at 08:05, 2 months 15 days ago ABL Diagnostics and CDL Pharma Secure €2.7 Million Contract Clinical Program Neurodegenerative Diseases International Contract ABL Diagnostics CDL Pharma
BRIEF published on 06/12/2026 at 08:05, 2 months 15 days ago ABL Diagnostics et CDL Pharma décrochent un contrat de 2,7 millions d'euros Maladies Neurodégénératives Contrat International Programme Clinique Diagnostics ABL CDL Pharma
Published on 08/28/2026 at 04:30, 14 minutes ago Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
Published on 08/27/2026 at 23:05, 5 hours 39 minutes ago Galway Metals Announces Filing of NI 43-101 Technical Report for Updated Clarence Stream Mineral Resource Estimate
Published on 08/27/2026 at 22:35, 6 hours 9 minutes ago Spirit Blockchain Capital Inc. Announces Shares for Services Issuance and Provides Technology Commercialization Update
Published on 08/27/2026 at 22:25, 6 hours 19 minutes ago Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
Published on 08/27/2026 at 16:30, 12 hours 14 minutes ago TDM Financial Retained for Investor Awareness Services
Published on 08/27/2026 at 19:15, 9 hours 28 minutes ago China Hongqiao Wins Asia Responsible Enterprise Awards for Third Consecutive Year
Published on 08/27/2026 at 19:15, 9 hours 28 minutes ago China Hongqiao distinguée pour la troisième année consécutive aux « Asia Responsible Enterprise Awards », ses pratiques en matière d'économie circulaire à nouveau reconnues à l'international
Published on 08/27/2026 at 18:36, 10 hours 7 minutes ago Haier Smart Home Reports H1 2026 Results: Q2 Revenue Grows Year-on-Year; Net Profit Improves Quarter-on-Quarter
Published on 08/26/2026 at 18:02, 1 day 10 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 10 hours ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 10 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 1 day 10 hours ago Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 1 day 10 hours ago KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires
